Myrsine melanophloeos
Myrsine melanophloeos · Accepted scientific name
Scientific literature: Very Sparse (4 studies) · ★☆☆☆☆
Myrsine melanophloeos is a botanical species recognized for its diverse pharmacological activities, including antiviral, anthelmintic, and antibacterial properties. The plant contains significant bioactive chemical constituents such as embelin and santonin, which contribute to its medicinal potential. Research indicates that various preparations, including aqueous extracts, DCM extracts, Q3R, and chloroformic stem bark extracts, can be utilized for therapeutic purposes. These extracts are particularly noted for their efficacy in addressing conditions such as helminthiases, Influenza A virus, and tuberculosis. By utilizing different parts of the plant like the stem and leaves, scientists continue to explore its vast biological capabilities.
- Synonyms
- Sideroxylon Melanophloeos · Rapanea Melanophloeos · 29 more
- Common names
- Not available
- Family
- Primulaceae
- Distribution
- Not available
- Plant Parts
- Stem · Leaf
Classification
Common Names
Myrsine melanophloeos is a distinctive plant frequently recognized by its common name, the Cape Beech. This species plays a vital role in its native ecosystem, offering structure and sustenance to local wildlife. Its dark, textured bark and characteristic foliage make it easily identifiable to many naturalists. By understanding its place within the environment, gardeners and conservationists can better appreciate its ecological value. Whether growing in the wild or managed in a landscape, this tree remains a significant component of its habitat.
Sources: Catalogue of Life (COL)
Synonyms
Myrsine melanophloeos is a botanical species recognized by a diverse array of scientific synonyms. Within various taxonomic records, this plant is frequently identified as Chrysophyllum melanophoeos or Chrysophyllum millerianum. Researchers also refer to the species under the name Heeria melanophloeos depending on the classification system used. Furthermore, the plant has been categorized as Manglilla melanophloeos in certain historical contexts. Finally, the synonym Manglilla venulosa is also linked to this complex web of botanical nomenclature.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Myrsine melanophloeos is a distinctive member of the kingdom Plantae that plays a specific role in its ecosystem. Within this vast botanical world, it is classified under the class Equisetopsida. It further belongs to the order Ericales, which helps scientists understand its evolutionary lineage. As a representative of the genus Myrsine, it shares certain structural characteristics with its close relatives. Finally, its taxonomic placement within the family Primulaceae solidifies its biological identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Primulaceae |
| Genus | Myrsine |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Myrsine melanophloeos is a resilient plant species primarily distributed across the diverse landscapes of Africa. Within the East Tropical Africa region, it can be found thriving in the territories of Kenya, Tanzania, and Uganda. Its presence also extends into Northeast Tropical Africa, where it inhabits various environments. Specifically, the species is documented growing within the borders of Ethiopia. Furthermore, its range continues through the expansive regions of Sudan and South Sudan.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Myrsine melanophloeos is a self-supporting plant that adopts the distinct growth form of a tree. Depending on its environmental conditions, this species exhibits significant variability in its vertical stature. While some specimens may remain relatively small at a minimum height of 1.21 m, others reach a more substantial minimum of 7.25 m. As the plant matures, it can continue to climb until it reaches a maximum height of 20 m. This diverse range of sizes allows the species to occupy various niches within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Myrsine melanophloeos, also referred to as Rapanea melanophloeos, demonstrates significant therapeutic potential across several pharmacological categories. Scientific investigations have confirmed its antiviral activity, particularly through the effectiveness of its methanol leaf extracts and isolated compounds against the influenza A virus. Furthermore, research into ethnobotanical treatments for diarrhea has highlighted its potent antibacterial properties against various microbial strains. The plant has also been evaluated for its anthelmintic potential, specifically regarding its ability to reduce fecal egg counts in parasitic models. Together, these findings provide a scientific basis for the traditional medicinal uses of this versatile species.
Compounds
Myrsine melanophloeos, also referred to as Rapanea melanophloeos, serves as a significant source of several bioactive compounds. Research indicates that this plant contains the chemical embelin, which has been studied for its potential in reducing faecal egg counts in certain parasite models. Furthermore, the species contains the compound santonin, a substance traditionally associated with anthelmintic properties. The plant is also a known source of quercetin-3-O-α-L-rhamnopyranoside, commonly known as Q3R. Studies have demonstrated that this specific isolated compound possesses significant immunomodulatory effects and potential antiviral activity against influenza.
Conditions
Myrsine melanophloeos, also identified as Rapanea melanophloeos, is traditionally utilized to treat various gut and lung infections. Research into its specific components has demonstrated that it can treat H1N1 (A/PR/8/34) infection through the antiviral properties of quercetin-3-O-α-L-rhamnopyranoside. The plant also shows significant effectiveness against the Influenza A virus (IAV) by utilizing immunomodulatory properties and affecting apoptosis pathways. In studies involving parasitic nematodes, the plant was evaluated for its ability to treat Heligmosomoides polygyrus infections, specifically by reducing faecal egg counts. These diverse therapeutic applications highlight the plant's broad medicinal potential against both viral and parasitic pathogens.
Preparations
Myrsine melanophloeos is prepared as an aqueous extract to investigate its potential toxicity and medicinal safety in rats. This plant is also processed as DCM extracts, which have demonstrated significant inhibitory activity against certain bacteria. Research has further isolated Q3R from the plant to evaluate its immunomodulatory and anti-influenza properties. Additionally, Myrsine melanophloeos is prepared as a chloroformic stem bark extract to assess its sub-acute toxicological effects. Various other extracts of the species are studied to evaluate their efficacy in treating parasitic infections.
Parts used
Myrsine melanophloeos, also known as Cape beech, is a tropical tree that holds significant value in African traditional medicine. Research has extensively utilized the plant's stem, specifically the bark, to develop aqueous and chloroformic extracts for medicinal testing. These studies on stem extracts have provided important data regarding the safety and toxicity levels of the plant when administered to subjects. Additionally, the leaves of the species serve as a vital part of its medicinal profile, particularly in the search for antiviral treatments. Specifically, methanol extracts derived from the leaves have demonstrated effective activity against the influenza A virus in laboratory settings.